Nanobiotechnology: Applications and Global Markets 2021-2026

The global market for nanobiotechnology should grow from $38.5 billion in 2021 to $68.4 billion by 2026, at a compound annual growth rate (CAGR) of 12.2% for the period of 2021-2026.

Report Scope:

The scope of this investigation includes the major viable nanobiotechnologies that are currently being implemented in various industries. The study scope includes the major nanotechnology formats that willor likely become commercialized within the next 5 years. Each technology format is analyzed to determine its market status, impact on future market segments and forecasted growth from 2021 through 2026. Technology issues and market-driving forces are discussed. Influencing factors, including drug delivery needs, biologic imaging trends and industry structure, are also discussed. The publisher examines nanobiotechnology companies and industry alliances, nanomaterial consumption, end-user industry, and market-driving forces.

The Report Includes:

105 tables
An updated review of the global market for nanobiotechnology applications
Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
Estimation of the market size and market forecast for nanobiotechnology applications, and corresponding market share analysis by molecular diagnostic application, therapeutic application, biopharmaceutical application, and geography
Highlights of key market dynamics, issues and trends, gaps and opportunities influencing current and future demand for nanobiotechnology in the global market and its sub-segments
Regional outlook and a country level assessment of nanobiotechnology applications market considering all macroeconomic factors, and Covid-19 impact analysis within the industry
Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
Discussion of major market segments and their respective technologies in the overall global market for nanobiotechnology
Assessment of major stakeholders and analysis of the key competitive landscape based on recent developments and segmental revenues
Profile descriptions of the leading industry players including Ablynx, Arrowhead Pharmaceuticals Inc., Celgene Corp., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co. Inc., Bio-Gate AG, Nanophase Technologies Corp., and Starpharma Holdings Ltd.

Frequently Asked Questions about the Global Nanobiotechnology Market

What is the estimated value of the Global Nanobiotechnology Market?

The Global Nanobiotechnology Market was estimated to be valued at $38.5 Billion in 2021.

What is the growth rate of the Global Nanobiotechnology Market?

The growth rate of the Global Nanobiotechnology Market is 12.2%, with an estimated value of $68.4 Billion by 2026.

What is the forecasted size of the Global Nanobiotechnology Market?

The Global Nanobiotechnology Market is estimated to be worth $68.4 Billion by 2026.

Who are the key companies in the Global Nanobiotechnology Market?

Key companies in the Global Nanobiotechnology Market include Ablynx, Arrowhead Pharmaceuticals Inc., Avadel Pharmaceuticals Plc, Bio, Gate Ag, Captivate Pharmaceuticals Llc, Celgene Corp., Cour Pharmaceutical and Eyepoint.

Report Attribute	Details
No. of Pages	126
Published	July 2021
Forecast Period	2021 - 2026
Estimated Market Value ( USD ) in 2021	$ 38.5 Billion
Forecasted Market Value ( USD ) by 2026	$ 68.4 Billion
Compound Annual Growth Rate	12.2%
Regions Covered	Global
No. of Companies Mentioned	25

Chapter 1 Introduction

Nanobiotechnology: Unique Fusion of Biotechnology and Nanotechnology
Market Definition
Study Goals and Objectives
Reasons for Doing the Study
Scope of the Report
Methodology
Intended Audience
Geographic Breakdown
What's New in This Updated Report
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Industry Overview

Introduction
Nanotechnology Value Chain
Bionanomaterials
Nanoparticles
Nanobiotechnology from Laboratory to Market
Nanobiotechnology Techniques
Nanobiotechnology Costs
Nanobiotechnology Applications Status
Life Cycle Status
Nanobiotechnology Growth Driving Forces

Chapter 4 Market Breakdown by Molecular Diagnostic Application

Introduction
Diagnostic Applications
Detection Application
Nanoarrays
Market Size Estimation and Forecast
Individual Target Robes
DNA Probe
RNA Probes
Market Size Estimation and Forecast
Protein Chips
Market Size Estimation and Forecast
Sparse Cell Detection
Market Size Estimation and Forecast
Nanotechnology as a Tool in Imaging
Why Nanoparticles are Important for Imaging
Genomics, Proteomics and Cell Biology Imaging
Emerging Applications of Imaging Reagents
Market Size Estimation and Forecast
Biopolymeric Nanoparticles in Diagnosis, Detection and Imaging
Market Size Estimation and Forecast
Market Size Estimation and Forecast

Chapter 5 Market Breakdown by Therapeutic Application

Introduction
Drug Delivery Applications
Nano-Based Drug Delivery Systems
Fundamentals of Nanotechnology-Based Techniques in Designing of Drugs
Market Size Estimation and Forecast
Gene Delivery
Market Size Estimation and Forecast
Cell/Gene Therapy
Market Size Estimation and Forecast
Reconstructive Surgery
Market Size Estimation and Forecast
Nanolaser Surgery
Market Size Estimation and Forecast
Other Therapeutic Applications
Liposomes
Surfaces
Market Size Estimation and Forecast

Chapter 6 Market Breakdown by Biopharmaceutical Application

Introduction
Nanopharmaceuticals
Development of Nanopharmaceuticals
Biomolecular Engineering
Market Size Estimation and Forecast
Tissue Engineering
Market Size Estimation and Forecast
Nanostructures
Market Size Estimation and Forecast
Bioprocessing
Market Size Estimation and Forecast
Other Biopharmaceutical Applications
Market Size Estimation and Forecast

Chapter 7 North American Market Outlook

Regional Market Overview

Chapter 8 European Market Outlook

Regional Market Overview

Chapter 9 Asia-Pacific Market Outlook

Regional Market Overview

Chapter 10 Latin America, Middle East and Africa Market Outlook

Regional Market Overview

Chapter 11 Company Profiles

Introduction
Ablynx
Arrowhead Pharmaceuticals Inc.
Avadel Pharmaceuticals Plc
Captivate Pharmaceuticals Llc
Celgene Corp.
Elitechgroup
Eyepoint
GlaxoSmithKline Plc
Johnson & Johnson
Merck & Co. Inc.
Nanobio Corp.
Nanophase Technologies Corp.
Starpharma Holdings Ltd.
Vectura Group Plc
Nanobiotechnology Startup Companies
Bio-Gate Ag
Cour Pharmaceutical
Iceutica
Keystone Nano
Meda Biotech
Nanocarrier
Nanomedical Diagnostics
Nuvascular Technologies Inc.
Sitka Biopharma
T2 Biosystems
Zylotherapeutics

List of Tables

Summary Table: Global Market for Nanobiotechnology, by Region, Through 2026
Table 1: Global Nanobiotechnology Industry Application Areas
Table 2: Features of Nanotechnologies
Table 3: Global Value Chain for Nanotechnologies
Table 4: Global Nanobiotechnology Materials
Table 5: Global Nanomaterials Applications Status
Table 6: Global Nanomaterials Life Cycle Status
Table 7: Global Nanobiotechnology Market Growth Driving Forces
Table 8: Global Market for Nanobiotechnology in Molecular Diagnostic Applications, by Type, Through 2026
Table 9: Global Comparative Analysis of Other Diagnostic Methods
Table 10: Overview of Nanoarray Features
Table 11: Areas of Impact for Nanoarray Technology
Table 12: Global Market for Nanobiotechnology in Nanoarrays, by Region, Through 2026
Table 13: Global Market for Nanobiotechnology in Individual Target Probe Applications, by Region, Through 2026
Table 14: Global Market for Nanobiotechnology in Protein Chip Applications, by Region, Through 2026
Table 15: Global Market for Nanobiotechnology in Sparse Cell Detection, by Region, Through 2026
Table 16: Global Key Biologic Imaging Nano-Reagent Types
Table 17: Global Market for Nanobiotechnology in Medical Imaging, by Region, Through 2026
Table 18: Global Market for Nanobiotechnology in Nanobiosensors, by Region, Through 2026
Table 19: Global Nanoparticles in Imaging Applications
Table 20: Global Market for Nanobiotechnology in Biodetection of Pathogens, by Region, Through 2026
Table 21: Global Market for Nanobiotechnology in Other Diagnostic Applications, by Region, Through 2026
Table 22: Global Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2026
Table 23: Benefits of Improved Drug Delivery
Table 24: Key Nanomaterials in Drug Delivery
Table 25: Global Market for Nanobiotechnology in Drug Delivery, by Region, Through 2026
Table 26: Global Market for Nanobiotechnology in Gene Delivery, by Region, Through 2026
Table 27: Global Market for Nanobiotechnology in Cell/Gene Therapy, by Region, Through 2026
Table 28: Global Market for Nanobiotechnology in Reconstructive Surgery, by Region, Through 2026
Table 29: Global Market for Nanobiotechnology in Nanolaser Surgery, by Region, Through 2026
Table 30: Global Market for Nanobiotechnology in Other Therapeutic Applications, by Region, Through 2026
Table 31: Global Market for Nanobiotechnology in Biopharmaceutical Applications, Through 2026
Table 32: Global Different Types of Nanocarriers and Their Main Advantages and Applications in Biomedical Fields.
Table 33: Global Market for Nanobiotechnology in Biomolecular Engineering, by Region, Through 2026
Table 34: Global Market for Nanobiotechnology in Tissue Engineering, by Region, Through 2026
Table 35: Global Market for Nanobiotechnology in DNA Nanostructures, by Region, Through 2026
Table 36: Global Market for Nanobiotechnology in Bioprocessing, by Region, Through 2026
Table 37: Global Market for Nanobiotechnology in Other Biopharmaceutical Applications, by Region, Through 2026
Table 38: North American Market for Nanobiotechnology in Molecular Diagnostic Applications, by Type, Through 2026
Table 39: North American Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2026
Table 40: North American Market for Nanobiotechnology in Biopharmaceutical Applications, by Type, Through 2026
Table 41: North American Market for Nanobiotechnology, by Application Area, Through 2026
Table 42: North American Market for Nanobiotechnology, by Country, Through 2026
Table 43: European Market for Nanobiotechnology in Molecular Diagnostic Applications, by Type, Through 2026
Table 44: European Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2026
Table 45: European Market for Nanobiotechnology in Biopharmaceutical Applications, by Type, Through 2026
Table 46: European Market for Nanobiotechnology, by Application Area, Through 2026
Table 47: European Market for Nanobiotechnology, by Country, Through 2026
Table 48: Asia-Pacific Market for Nanobiotechnology in Molecular Diagnostic Applications Market, by Type, Through 2026
Table 49: Asia-Pacific Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2026
Table 50: Asia-Pacific Market for Nanobiotechnology in Biopharmaceutical Applications, by Type, Through 2026
Table 51: Asia-Pacific Market for Nanobiotechnology, by Application Area, Through 2026
Table 52: Asia-Pacific Market for Nanobiotechnology, by Country, Through 2026
Table 53: LAMEA Market for Nanobiotechnology in Molecular Diagnostic Applications, by Type, Through 2026
Table 54: LAMEA Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2026
Table 55: LAMEA Market for Nanobiotechnology Biopharmaceutical Applications, by Type, Through 2026
Table 56: LAMEA Market for Nanobiotechnology, by Application Area, Through 2026
Table 57: LAMEA Market for Nanobiotechnology, by Country, Through 2026
Table 58: Ablynx: Company Information
Table 59: Ablynx: Company Product and Service Benchmarking
Table 60: Ablynx: Company Recent Developments, February 2021
Table 61: Arrowhead Pharmaceuticals Inc.: Company Information
Table 62: Arrowhead Pharmaceuticals Inc.: Company Revenue, 2016-2020
Table 63: Arrowhead Pharmaceuticals Inc.: Company Product and Service Benchmarking
Table 64: Arrowhead Pharmaceuticals Inc.: Company Recent Developments, Feb 2021
Table 65: Avadel Pharmaceuticals PLC: Company Information
Table 66: Avadel Pharmaceuticals PLC: Company Product and Service Benchmarking
Table 67: Avadel Pharmaceuticals PLC: Company Recent Developments, February 2021
Table 68: Cativate Pharmaceuticals LLC: Company Information
Table 69: CaPtivate Pharmaceuticals LLC: Company Product and Service Benchmarking
Table 70: Celgene Corp.: Company Information
Table 71: Celgene Corp.: Company Product and Service Benchmarking
Table 72: ELITechGroup: Company Information
Table 73: ELITechGroup: Company Product and Service Benchmarking
Table 74: ELITechGroup: Company Recent Developments, February 2021
Table 75: Eyepoint.: Company Information
Table 76: Eyepoint.: Company Revenue, 2016-2020
Table 77: Eyepoint.: Company Product and Service Benchmarking
Table 78: Eyepoint.: Company Recent Developments, February 2021
Table 79: GlaxoSmithKline PLC: Company Information
Table 80: GlaxoSmithKline PLC: Company Revenue, 2016-2020
Table 81: GlaxoSmithKline PLC: Company Product and Service Benchmarking
Table 82: GlaxoSmithKline PLC: Company Recent Developments, February 2021
Table 83: Johnson & Johnson: Company Information
Table 84: Johnson & Johnson: Company Revenue 2016-2020
Table 85: Johnson & Johnson: Company Product and Service Benchmarking
Table 86: Johnson & Johnson: Company Recent Developments, February 2021
Table 87: Merck & Co. Inc.: Company Information
Table 88: Merck & Co. Inc.: Company Revenue, 2016-2020
Table 89: Merck & Co. Inc.: Company Product and Service Benchmarking
Table 90: Merck & Co. Inc.: Company Recent Developments, February 2020
Table 91: NanoBio Corp.: Company Information
Table 92: NanoBio Corp.: Company Product and Service Benchmarking
Table 93: NanoBio Corp.: Company Recent Developments, February 2021
Table 94: Nanophase Technologies Corp.: Company Information
Table 95: Nanophase Technologies Corp.: Company Revenue, 2016-2020
Table 96: Nanophase Technologies Corp.: Company Product and Service Benchmarking
Table 97: Nanophase Technologies Corp.: Company Recent Developments, February 2021
Table 98: Starpharma Holdings Ltd.: Company Information
Table 99: Starpharma Holdings Ltd.: Company Revenue, 2016-2020
Table 100: Starpharma Holdings Ltd.: Company Product and Service Benchmarking
Table 101: Starpharma Holdings Ltd.: Company Recent Developments, February 2021
Table 102: Vectura Group PLC: Company Information
Table 103: Vectura Group PLC: Company Revenue, 2016-2020
Table 104: Vectura Group PLC: Company Product and Service Benchmarking
Table 105: Vectura Group PLC: Company Recent Developments, February 2021

List of Figures

Figure A: Nanobiotechnology and the Biological System
Summary Figure: Global Market for Nanobiotechnology, by Region, 2021-2026
Figure 1: Global Market Shares of Nanobiotechnology in Molecular Diagnostic Applications, by Type, 2021
Figure 2: Global Market Shares of Nanobiotechnology in Nanoarray Applications, by Region, 2021
Figure 3: Global Market Shares of Nanobiotechnology in Individual Target Probe Applications, by Region, 2021
Figure 4: Protein Chips Manufacturing Process Overview
Figure 5: Global Market Shares of Nanobiotechnology in Protein Chip Applications, by Region, 2021
Figure 6: Global Market Shares of Nanobiotechnology in Sparse Cell Detection, by Region, 2021
Figure 7: Global Market Shares of Nanobiotechnology in Medical Imaging, by Region, 2021
Figure 8: Global Market Shares of Nanobiotechnology in Nanobiosensors, by Region, 2021
Figure 9: Global Market Shares of Nanobiotechnology in Biodetection of Pathogens, by Region, 2021
Figure 10: Global Market Shares of Nanobiotechnology in Other Diagnostic Applications, by Region, 2021
Figure 11: Global Market Shares of Nanobiotechnology in Therapeutic Applications, by Type, 2021
Figure 12: Global Market Shares of Nanobiotechnology in Drug Delivery, by Region, 2021
Figure 13: Global Market Shares of Nanobiotechnology in Gene Delivery, by Region, 2021
Figure 14: Global Market Shares of Nanobiotechnology in Reconstructive Surgery, by Region, 2021
Figure 15: Global Market Shares of Nanobiotechnology in Nanolaser Surgery, by Region, 2021
Figure 16: Global Market Shares of Nanobiotechnology in Other Therapeutic Applications, by Region, 2021
Figure 17: Global Market Shares of Nanobiotechnology in Biopharmaceutical Applications, 2021
Figure 18: Global Market Shares of Nanobiotechnology in Biomolecular Engineering, by Region, 2021
Figure 19: Global Market Shares of Nanobiotechnology in Tissue Engineering, by Region, 2021
Figure 20: Nanostructures and Devices
Figure 21: Global Market Shares of Nanobiotechnology in DNA Nanostructures, by Region, 2021
Figure 22: Global Market Shares of Nanobiotechnology in Bioprocessing, by Region, 2021
Figure 23: Global Market Shares of Nanobiotechnology in Other Biopharmaceutical Applications, by Region, 2021
Figure 24: North American Market Shares of Nanobiotechnology in Molecular Diagnostic Applications, by Type, 2021
Figure 25: North American Market Shares of Nanobiotechnology in Therapeutic Applications, by Type, 2021
Figure 26: North American Market Shares of Nanobiotechnology in Biopharmaceutical Applications, by Type, 2021
Figure 27: North American Market Shares of Nanobiotechnology, by Application Area, 2021
Figure 28: North American Market Shares of Nanobiotechnology, by Country, 2021
Figure 29: European Market Shares of Nanobiotechnology in Molecular Diagnostic Applications, by Type, 2021
Figure 30: European Market Shares of Nanobiotechnology in Therapeutic Applications, by Type, 2021
Figure 31: European Market Shares of Nanobiotechnology in Biopharmaceutical Applications, by Type, 2021
Figure 32: European Market Shares of Nanobiotechnology, by Application Area, 2021
Figure 33: European Market Shares of Nanobiotechnology, by Country, 2021
Figure 34: Asia-Pacific Market Shares of Nanobiotechnology in Molecular Diagnostic Applications, by Type, 2021
Figure 35: Asia-Pacific Market for Nanobiotechnology in Therapeutic Applications, by Type, Through 2021
Figure 36: Asia-Pacific Market Shares of Nanobiotechnology in Biopharmaceutical Applications, by Type, 2021
Figure 37: Asia-Pacific Market Shares of Nanobiotechnology, by Application Area, 2021
Figure 38: Asia-Pacific Market Shares of Nanobiotechnology, by Country, 2021
Figure 39: LAMEA Market Shares of Nanobiotechnology in Molecular Diagnostic Applications, by Type, 2021
Figure 40: LAMEA Market Shares of Nanobiotechnology in Therapeutic Applications, by Type, 2021
Figure 41: LAMEA Market Shares of Nanobiotechnology in Biopharmaceutical Applications, by Type, 2021
Figure 42: LAMEA Market Shares of Nanobiotechnology, by Application Area, 2021
Figure 43: LAMEA Market Shares of Nanobiotechnology, by Country, 2021

Samples

LOADING...

Executive Summary

Biotechnology and nanotechnology are two of the most promising technologies of the 21st century. The designing, development and application of materials and equipment whose most functional structure is on a nanometer scale is defined as nanotechnology. While nanotechnology involves the development of materials, devices or other structures in 1-100 nanometers or more size range, biologics deals with biological subjects including micro-organisms in metabolic and other physiological processes. Nanobiotechnology combines these two technologies in order to develop and deploy many useful life studies tools, and thus it can play a vital role in production of many healthcare products. In many industries, including the biotech industry, nanotechnology has emerged as a technology that enables wide range of applications. Due to the unique demands in the biotechnology industry, there have been specific platforms for nanomaterials that present opportunities for innovation-led sales growth. Medicines, diagnostics, research tools, microbicides and DNA sequencing industries have benefited from nanotechnology. The ability of nanotechnology platforms to cut across applications and industries suggests exciting growth opportunities for the future.

Reasons for Doing the Study

Given the emerging nature of this industry, it is time to analyze the key trends, markets and industry dynamics to provide a useful basis for decision-making.

In many industries, including the biotechnology industry, nanotechnology is emerging as the platform for materials. The unique properties of nanomaterials allow for added value in a variety of applications, from drug encapsulation and release to biological imaging. At the same time, the pharmaceutical industry is seeking ways to expand patenting and improve pharmacokinetics. In addition, the diagnostics industry is looking for ways to improve the molecular image of new pharmaceutical products. These converging forces result in nanobiotechnology being used in a variety of applications and materials.

Several nanotechnology platforms are already established and providing significant revenues in drug delivery applications, as well as diagnostics, microbicides and R&D tools. Significant nanotechnology drug formats include polymer, liposomal and nanocrystal drugs. Diagnostic and microbicide formats include nanoparticles, quantum dots and dendrimers. Nanopore formats are emerging in third generation DNA sequencing applications.

The purpose of this report is to provide a global, regional and national assessment of the nanobiotechnology application market’s potential as well as its existing products, services, future market sizes. This is important because nanobiotechnology markets vary substantially in terms of regional characteristics and depending on the technology in question.